U.S. Physical Therapy, Inc.
USPH
$74.75
$0.330.44%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 642.78M | 623.05M | 598.53M | 574.89M | 553.64M |
| Total Other Revenue | 130.56M | 127.90M | 123.68M | 117.43M | 110.79M |
| Total Revenue | 773.34M | 750.95M | 722.20M | 692.33M | 664.43M |
| Cost of Revenue | 602.32M | 586.04M | 562.90M | 541.65M | 518.20M |
| Gross Profit | 171.02M | 164.91M | 159.30M | 150.67M | 146.24M |
| SG&A Expenses | 69.26M | 66.71M | 63.68M | 60.45M | 58.29M |
| Depreciation & Amortization | 21.06M | 22.30M | 20.97M | 19.52M | 17.87M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 692.64M | 675.05M | 647.54M | 621.63M | 594.35M |
| Operating Income | 80.70M | 75.90M | 74.66M | 70.70M | 70.08M |
| Income Before Tax | 77.81M | 81.18M | 70.64M | 62.78M | 60.21M |
| Income Tax Expenses | 19.81M | 19.85M | 17.18M | 15.33M | 14.61M |
| Earnings from Continuing Operations | 58.01 | 61.32 | 53.46 | 47.45 | 45.60 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -18.42M | -16.65M | -15.30M | -14.17M | -14.18M |
| Net Income | 39.58M | 44.67M | 38.16M | 33.28M | 31.42M |
| EBIT | 80.70M | 75.90M | 74.66M | 70.70M | 70.08M |
| EBITDA | 103.09M | 99.34M | 96.66M | 91.15M | 88.76M |
| EPS Basic | 1.42 | 2.38 | 2.29 | 2.17 | 1.84 |
| Normalized Basic EPS | 1.75 | 1.69 | 1.81 | 1.79 | 1.85 |
| EPS Diluted | 1.42 | 2.38 | 2.29 | 2.17 | 1.84 |
| Normalized Diluted EPS | 1.75 | 1.69 | 1.81 | 1.79 | 1.85 |
| Average Basic Shares Outstanding | 60.70M | 60.62M | 60.50M | 60.37M | 60.26M |
| Average Diluted Shares Outstanding | 60.70M | 60.62M | 60.50M | 60.37M | 60.26M |
| Dividend Per Share | 1.80 | 1.79 | 1.78 | 1.77 | 1.76 |
| Payout Ratio | 69.13% | 60.80% | 70.63% | 79.75% | 84.46% |